January 6, 2020: FemPulse Announces Issuance of Patents in China and Australia

Posted in Press Release | January 6, 2020

FemPulse Corporation announced the issuance of two patents from China and Australia covering methods of stimulation of autonomic nerve plexuses in women.

Read the Rest of the Article

Contact Us

office@fempulse.com

651-321-3458

Please do not include personal identifying information such as your birth date, or personal medical information in any emails you send to us.

FemPulse™ and The Elegant Solution™are trademarks of FemPulse Corporation. Other companies, products, and journals referenced on this site are registered or unregistered trademarks of their respective owners.

Important information: Medical devices are regulated by the competent regulatory body in each country.FemPulse devices are not yet approved or cleared for sale, including by the U.S. Food and Drug Administration (FDA), and are not available other than potentially for controlled clinical investigation under NSR classification with IRB or EC approval. The content of this website is intended to be educational and informational and makes no formal or substantiated claims about FemPulse's devices in development. All statements related to design intent require future verification of validity.

2024 All Rights Reserved. Medical website design by Glacial Multimedia, Inc. ©

If you are using a screen reader and are having problems using this website, please contact us.

Accessibility Disclaimer

January 6, 2020: FemPulse Announces Issuance of Patents in China and Australia

Recent Posts

Categories

Archives

Contact Us